Epizyme Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2022, Epizyme's inventory turnover ratio sequentially decreased to 3.49 in the second quarter 2022, otherwise the ratio remained above the average, as EPZM's markets remain strong.Epizyme's average inventory processing period in the Jun 30 2022 quarter, has increased to 105 days, from 92 days, in the Mar 31 2022 quarter.

Within Healthcare sector 142 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1163 in the first quarter 2022, to 1231.

EPZM Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Epizyme Inc. Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

EPZM Inventory Turnover Ratio	(Jun 30 2022) II. Quarter	(Mar 31 2022) I. Quarter	(Dec 31 2021) IV. Quarter	(Sep 30 2021) III. Quarter	(Jun 30 2021) II. Quarter
Y / Y Inventory Growth	416.01 %	-69 %	-69.26 %	-81.35 %	-89.11 %
Y / Y Cost of Sales Growth	107.42 %	-7.57 %	73.01 %	24.32 %	143.84 %
Inventory Turnover Ratio (TTM)	3.49	3.95	2.04	1.32	1.02
EPZM's Total Ranking	# 1231	# 1163	# 1217	# 941	# 1730
Average inventory processing period	105	92	179	277	359
Seq. Inventory Growth	20.64 %	42.85 %	111.44 %	41.62 %	-92.75 %
Seq. Cost of Sales Growth	96.02 %	-16.39 %	57.78 %	-19.78 %	-12.65 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 49
Healthcare Sector	# 143
Overall Market	# 1231

Inventory Turnover Ratio Statistics
High	Average	Low
3.95	1.88	0.67
(Mar 31 2022)		(Dec 31 2020)

EPZM Company Profile >> Back to EPZM Efficiency Comparisons >> Compare EPZM Inventory Turnover Ratio to its Competitors

Financial Statements
Epizyme's Inventories	$ 6 Millions	Visit EPZM's Balance sheet
Epizyme's Cost of Revenues TTM	$ 13 Millions	Visit EPZM's Income Statement
What are EPZM's Sales?		Visit EPZM's Sales by Segment

Other Inventory Turnover Ratios
Epizyme's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
EPZM's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for EPZM's Competitors
Inventory Turnover Ratio for EPZM's Suppliers
Inventory Turnover Ratio for EPZM's Customers

You may also want to know
EPZM's Sales Growth Rates	EPZM's Pe Price to earnings ratio	EPZM's Receivables Turnover Ratio	EPZM's Stock Quote
EPZM's Net Income Growth Rates	EPZM's Ps Price to Sales ratio	EPZM's Sales per Employee	EPZM's Asset Turnover Ratio
EPZM's Net Margin	EPZM's Pb Price to Book ratio	EPZM's Financial Strength Ratios	EPZM's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2022, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Jun 30 2022	Inventories at quarter ending Jun 30 2022
Collegium Pharmaceutical Inc	6.37	$ 307.035 Millions	$ 48 Millions
Semler Scientific inc	6.34	$ 5.480 Millions	$ 1 Millions
Aveo Pharmaceuticals Inc	6.27	$ 9.276 Millions	$ 1 Millions
Fonar Corporation	6.15	$ 13.308 Millions	$ 2 Millions
Carlisle Companies Incorporated	6.12	$ 4,078.500 Millions	$ 666 Millions
Vyant Bio Inc	6.12	$ 2.892 Millions	$ 0 Millions
Patterson Companies Inc	6.05	$ 5,084.376 Millions	$ 840 Millions
Logicmark Inc	5.81	$ 5.303 Millions	$ 1 Millions
Guardion Health Sciences Inc	5.77	$ 5.324 Millions	$ 1 Millions
Veracyte Inc	5.71	$ 68.546 Millions	$ 12 Millions
Kaya Holdings Inc	5.67	$ 0.239 Millions	$ 0 Millions
Inogen Inc	5.66	$ 185.730 Millions	$ 33 Millions
Avantor Inc	5.66	$ 5,001.800 Millions	$ 884 Millions
Nexgel Inc	5.60	$ 1.699 Millions	$ 0 Millions
Integer Holdings Corporation	5.60	$ 941.472 Millions	$ 168 Millions
Ufp Technologies Inc	5.53	$ 206.102 Millions	$ 37 Millions
Biomerica Inc	5.53	$ 15.894 Millions	$ 3 Millions
Steris Plc	5.52	$ 1,811.939 Millions	$ 328 Millions
Aquestive Therapeutics Inc	5.50	$ 22.722 Millions	$ 4 Millions
Cormedix Inc	5.33	$ 0.075 Millions	$ 0 Millions
Ginkgo Bioworks Holdings Inc	5.17	$ 30.556 Millions	$ 6 Millions
Abbvie Inc	5.17	$ 16,932.000 Millions	$ 3,275 Millions
Steris Plc	5.14	$ 2,665.255 Millions	$ 519 Millions
Harrow Inc	5.10	$ 22.524 Millions	$ 4 Millions
Incyte Corporation	5.09	$ 176.993 Millions	$ 35 Millions
Biotricity Inc	5.08	$ 3.386 Millions	$ 1 Millions
Lftd Partners Inc	4.99	$ 27.299 Millions	$ 5 Millions
Catalent Inc	4.93	$ 3,312.300 Millions	$ 672 Millions
Myomo Inc	4.89	$ 4.576 Millions	$ 1 Millions
Henry Schein Inc	4.86	$ 8,908.188 Millions	$ 1,835 Millions

Date modified: 2026-08-29T17:17:18+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.